Molecular Docking of Bacosides with Tryptophan Hydroxylase: A Model to Understand the Bacosides Mechanism

doi:10.1007/s13659-014-0031-5

应用天然产物 ›› 2014, Vol. 4 ›› Issue (4): 251-255.DOI: 10.1007/s13659-014-0031-5

• Short communication • 上一篇

Molecular Docking of Bacosides with Tryptophan Hydroxylase: A Model to Understand the Bacosides Mechanism

David Mary Rajathei¹, Jayakumar Preethi², Hemant K. Singh³, Koilmani Emmanuvel Rajan²

1. Department of Bioinformtics, Bharathidasan University, Tiruchirappalli 620024, India;
2. Department of Animal Science, School of Life Sciences, Bharathidasan University, Tiruchirappalli 620024, India;
3. Laboratories of CNS Disorder, Learning & Memory, Division of Pharmacology, Central Drug Research Institute, Lucknow 226031, India

收稿日期:2014-05-13 修回日期:2014-06-30 出版日期:2014-08-24 发布日期:2018-02-11
通讯作者: Koilmani Emmanuvel Rajan,e-mail:emmanuvel1972@yahoo.com
基金资助:
We are grateful to the editor and anonymous referees for their comments that improved the final version of this article.

Molecular Docking of Bacosides with Tryptophan Hydroxylase: A Model to Understand the Bacosides Mechanism

David Mary Rajathei¹, Jayakumar Preethi², Hemant K. Singh³, Koilmani Emmanuvel Rajan²

1. Department of Bioinformtics, Bharathidasan University, Tiruchirappalli 620024, India;
2. Department of Animal Science, School of Life Sciences, Bharathidasan University, Tiruchirappalli 620024, India;
3. Laboratories of CNS Disorder, Learning & Memory, Division of Pharmacology, Central Drug Research Institute, Lucknow 226031, India

Received:2014-05-13 Revised:2014-06-30 Online:2014-08-24 Published:2018-02-11
Supported by:
We are grateful to the editor and anonymous referees for their comments that improved the final version of this article.

摘要/Abstract

摘要： Tryptophan hydroxylase(TPH) catalyses L-tryptophan into 5-hydroxy-L-tryptophan, which is the first and ratelimiting step of serotonin(5-HT) biosynthesis. Earlier, we found that TPH2 up-regulated in the hippocampus of postnatal rats after the oral treatment of Bacopa monniera leaf extract containing the active compound bacosides. However, the knowledge about the interactions between bacosides with TPH is limited. In this study, we take advantage of in silico approach to understand the interaction of bacoside-TPH complex using three different docking algorithms such as HexDock, PatchDock and AutoDock. All these three algorithms showed that bacoside A and A3 well fit into the cavity consists of active sites. Further, our analysis revealed that major active compounds bacoside A3 and A interact with different residues of TPH through hydrogen bond. Interestingly, Tyr235, Thr265 and Glu317 are the key residues among them, but none of them are either at tryptophan or BH4 binding region. However, its note worthy to mention that Tyr 235 is a catalytic sensitive residue, Thr265 is present in the flexible loop region and Glu317 is known to interacts with Fe. Interactions with these residues may critically regulate TPH function and thus serotonin synthesis. Our study suggested that the interaction of bacosides(A₃/A) with TPH might up-regulate its activity to elevate the biosynthesis of 5-HT, thereby enhances learning and memory formation.

关键词: Serotonin, Tryptophan hydroxylase, Bacosides, Docking

Abstract: Tryptophan hydroxylase(TPH) catalyses L-tryptophan into 5-hydroxy-L-tryptophan, which is the first and ratelimiting step of serotonin(5-HT) biosynthesis. Earlier, we found that TPH2 up-regulated in the hippocampus of postnatal rats after the oral treatment of Bacopa monniera leaf extract containing the active compound bacosides. However, the knowledge about the interactions between bacosides with TPH is limited. In this study, we take advantage of in silico approach to understand the interaction of bacoside-TPH complex using three different docking algorithms such as HexDock, PatchDock and AutoDock. All these three algorithms showed that bacoside A and A3 well fit into the cavity consists of active sites. Further, our analysis revealed that major active compounds bacoside A3 and A interact with different residues of TPH through hydrogen bond. Interestingly, Tyr235, Thr265 and Glu317 are the key residues among them, but none of them are either at tryptophan or BH4 binding region. However, its note worthy to mention that Tyr 235 is a catalytic sensitive residue, Thr265 is present in the flexible loop region and Glu317 is known to interacts with Fe. Interactions with these residues may critically regulate TPH function and thus serotonin synthesis. Our study suggested that the interaction of bacosides(A₃/A) with TPH might up-regulate its activity to elevate the biosynthesis of 5-HT, thereby enhances learning and memory formation.

Key words: Serotonin, Tryptophan hydroxylase, Bacosides, Docking

David Mary Rajathei, Jayakumar Preethi, Hemant K. Singh, Koilmani Emmanuvel Rajan. Molecular Docking of Bacosides with Tryptophan Hydroxylase: A Model to Understand the Bacosides Mechanism[J]. 应用天然产物, 2014, 4(4): 251-255.

参考文献

1. P. Jain, D.K. Kulshreshtha, Phytochemistry 33, 449-451 (1993)
2. S. Rastogi, R. Pal, D.K. Kulshreshtha, Phytochemistry 36, 133-137 (1994)
3. S. Rastogi, D.K. Kulshreshtha, Ind. J. Chem. 38B, 353-356 (1999)
4. S. Garai, S.B. Mahato, K. Ohtani, K. Yamasaki, Phytochemistry 42, 815-820 (1996)
5. S. Garai, S.B. Mahato, K. Ohtani, K. Yamasaki, Phytochemistry 43, 447-449 (1996)
6. S.B. Mahato, S. Garai, A.K. Chakravarty, Phytochemistry 53, 711-714 (2000)
7. C.C. Hou, S.J. Lin, J.T. Cheng, F.L. Hsu, J. Nat. Prod. 65, 1759-1763 (2002)
8. A.K. Chakravarty, T. Sarkar, T. Nakane, N. Kawahara, K. Masuda, Chem. Pharm. Bull. 50, 1616-1618 (2002)
9. A.K. Chakravarty, S. Garai, K. Masuda, T. Nakane, N. Kawahara, Chem. Pharm. Bull. 51, 215-217 (2003)
10. H.K. Singh, B.N. Dhawan, J. Ethnopharmacol. 5, 205-214 (1982)
11. D. Vohora, S.N. Pal, K.K. Pillai, J. Ethnopharmacol. 71, 383-390 (2000)
12. S. Prabhakar, M.K. Saraf, P. Pandhi, A. Anand, Psychopharmacology 200, 27-37 (2008)
13. S.K. Hota, K. Barhwal, I. Baitharu, D. Prasad, S.B. Singh, G. Ilavazhagan, Neurobiol. Dis. 34, 23-39 (2009)
14. M.K. Saraf, S. Prabhakar, A. Anand, Neuroscience 160, 149-155 (2009)
15. M.K. Saraf, A. Anand, S. Prabhakar, Neurochem. Res. 35, 279-287 (2010)
16. K.E. Rajan, H.K. Singh, A. Parkavi, D.C. Prisila, Neurochem. Res. 36, 2136-2144 (2011)
17. D.C. Prisila, H.K. Singh, J. Preethi, K.E. Rajan, J. Neurosci. Res. 90, 2053-2064 (2012)
18. H.K. Singh, B.N. Dhawan, J. Pharmacol. 29, S359-S365 (1997)
19. S.K. Bhattacharya, A. Bhattacharya, A. Kumar, Phytother. Res. 14, 174-179 (2000)
20. A. Das, G. Shanker, C. Nath, R. Pal, S. Singh, H. Singh, Pharm. Biochem. Behav. 73, 893-900 (2002)
21. N. Sheikh, A. Ahmad, K.B. Siripurapu, V.K. Kuchibhotla, S. Singh, G. Palit, J. Ethnopharmacol. 111, 671-676 (2007)
22. M.K. Saraf, S. Prabhakar, A. Anand, Neuroscience 160, 149-155 (2009)
23. J. Mathew, J. Paul, M.S. Nandhu, C.S. Paulose, Fitoterapia 81(5), 315-322 (2010)
24. D.C. Prisila, A. Ganesh, P. Geraldine, M.A. Akbarsha, K.E. Rajan, J. Ethnopharmacol. 134, 55-61 (2011)
25. A. Barzilai, T.E. Kennedy, J.D. Sweatt, E.R. Kandel, Neuron 2, 1577-1586 (1989)
26. M. Meeter, L. Talamini, J.A. Schmitt, W.J. Riedel, Neuropsychopharmacology 31, 712-720 (2006)
27. Y.Y. Huang, E.R. Kandel, J. Neurosci. 27, 3111-3119 (2007)
28. R.M. Weragoda, E.T. Walters, J. Neurophysiol. 98, 1231-1239 (2007)
29. W. Lovenberg, E. Jequier, A. Sjoerdsma, Science 155, 217-219 (1967)
30. A. Martínez, P.M. Knappskog, J. Haavik, Curr. Med. Chem. 8, 1077-1091 (2001)
31. D.J. Walther, J.U. Peter, S. Bashammakh, H. Hortnagl, M. Voits, H. Fink, M. Bader, Science 299, 76 (2003)
32. X. Zhang, J. Beaulieu, T.D. Sotnikova, R.R. Gainetdinov, M.G. Caron, Science 305, 217 (2004)
33. D.J. Walther, M. Bader, Biochem. Pharmacol. 66, 1673-1680 (2003)
34. P.D. Patel, C. Pontrello, S. Burke, Biol. Psychiatry 55, 428-433 (2004)
35. J. McKinney, P.M. Knappskog, J. Haavik, J. Neurochem. 92, 311-320 (2005)
36. I. Winge, J.A. McKinney, M. Ying, C.S. D'Santos, R. Kleppe, P.M. Knappskog, J. Haavik, Biochem. J. 410, 195-204 (2008)
37. F. Chamas, L. Srova, E.L. Sabban, Neurosci. Lett. 267, 157-160 (1999)
38. S.W. Kim, S.Y. Pak, O. Hwang, Mol. Pharmacol. 61, 778-785 (2002)
39. L. Wang, H. Erlandsen, J. Haavik, P.M. Knappskog, R.C. Biochemistry 41, 12569-12574 (2002)
40. H. Sato, L.M. Shewchuk, J. Tang, J. Chem. Inf. Model. 46, 2552-2562 (2006)
41. D.B. Kitchen, H. Decornez, R.F. John, B. Jurgen, Nat. Rev. Drug. Discov. 3, 935-949 (2004)
42. W.M. Pardridge, J. Neurovirol. 5, 556-569 (1999)
43. D.B. Kitchen, H. Decornez, J.R. Furr, J. Bajorath, Nat. Rev. Drug. Discov. 3, 935-949 (2004)
44. M.S. Windahl, C.R. Petersen, H.E. Christensen, P. Harris, Biochemistry 47, 12087-12094 (2008)
45. J. McKinney, K. Teigen, N.A. Froystein, C. Salaun, P.M. Knappskog, J. Haavik, A. Martinez, Biochemistry 40, 15591-15601 (2000)
46. G.C.T. Jiang, G.J. Yohrling IV, J.D. Schmitt, K.E. Vrana, J. Mol. Biol. 302, 1005-1017 (2000)
47. N.M. O'Boyle, M. Banck, C.A. James, C. Morley, T. Vandermeersch, G.R. Hutchison, J. Cheminform. 3, 33 (2011)
48. D. Schneidman-Duhovny, Y. Inbar, R. Nussinov, H.J. Wolfson, Nucl. Acids. Res. 33, W363-W367 (2005)
49. G.M. Morris, R. Huey, W. Lindstrom, M.F. Sanner, R.K. Belew, D.S. Goodsell, A.J. Olson, J. Comput. Chem. 16, 2785-2791 (2009)
50. G. Macindoe, L. Mavridis, V. Venkatraman, M.D. Devignes, D.W. Ritchie, Nucl. Acids Res. 38, W445-W449 (2010)
51. N. Guex, M.C. Peitsch, Electrophoresis 18, 2714-2723 (1997)

[1]	Orawan Jongsomjainuk, Jutatip Boonsombat, Sanit Thongnest, Hunsa Prawat, Paratchata Batsomboon, Sitthivut Charoensutthivarakul, Saroj Ruchisansakun, Kittipong Chainok, Jitnapa Sirirak, Chulabhorn Mahidol, Somsak Ruchirawat. Kaemtakols A–D, highly oxidized pimarane diterpenoids with potent anti-inflammatory activity from Kaempferia takensis[J]. 应用天然产物, 2023, 13(6): 55-55.
[2]	Mohammed A. Dahab, Mostafa M. Hegazy, Hatem S. Abbass. Hordatines as a Potential Inhibitor of COVID-19 Main Protease and RNA Polymerase: An In-Silico Approach[J]. 应用天然产物, 2020, 10(6): 453-462.
[3]	Rohan R. Narkhede, Ashwini V. Pise, Rameshwar S. Cheke, Sachin D. Shinde. Recognition of Natural Products as Potential Inhibitors of COVID-19 Main Protease (Mpro): In-Silico Evidences[J]. 应用天然产物, 2020, 10(5): 297-306.
[4]	Jean J. K. Bankeu, Hira Sattar, Yannick S. F. Fongang, Syeda W. Muhammadi, Conrad V. Simoben, Fidele Ntie-Kang, Guy R. T. Feuya, Marthe A. T. Tchuenmogne, Mehreen Lateef, Bruno N. Lenta, Muhammad S. Ali, Augustin S. Ngouela. Synthesis, Urease Inhibition and Molecular Modelling Studies of Novel Derivatives of the Naturally Occurring β-Amyrenone[J]. 应用天然产物, 2019, 9(1): 49-60.
[5]	Yinglan Pu, Hui Liu, Yeheng Zhou, Jiale Peng, Yaping Li, Penghua Li, Yingying Li, Xingyong Liu, Li Zhang. In silico Discovery of Novel FXa Inhibitors by Pharmacophore Modeling and Molecular Docking[J]. 应用天然产物, 2017, 7(3): 249-256.
[6]	Mehtab Parveen, Faheem Ahmad, Ali Mohammed Malla, Shaista Azaz, Mahboob Alam, Omer A. Basudan, Manuela Ramos Silva, Pedro S. Pereira Silva. Acetylcholinesterase and Cytotoxic Activity of Chemical Constituents of Clutia lanceolata Leaves and its Molecular Docking Study[J]. 应用天然产物, 2016, 6(6): 267-278.
[7]	Christian Bäcker, Malgorzata N. Drwal, Robert Preissner, Ulrike Lindequist. Inhibition of DNA-Topoisomerase I by Acylated Triterpene Saponins from Pittosporum angustifolium Lodd[J]. 应用天然产物, 2016, 6(2): 141-147.
[8]	A. Anita Margret, T. Nargis Begum, S. Parthasarathy, S. Suvaithenamudhan. A Strategy to Employ Clitoria ternatea as a Prospective Brain Drug Confronting Monoamine Oxidase (MAO) Against Neurodegenerative Diseases and Depression[J]. 应用天然产物, 2015, 5(6): 293-306.

Molecular Docking of Bacosides with Tryptophan Hydroxylase: A Model to Understand the Bacosides Mechanism

Molecular Docking of Bacosides with Tryptophan Hydroxylase: A Model to Understand the Bacosides Mechanism

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 8

编辑推荐

Metrics

本文评价